Inventor · disambiguated record
Christopher L. Vandeusen
Also filed as: VANDEUSEN CHRISTOPHER L · VANDEUSEN CHRISTOPHER LOREN
14 granted patents·10 pending applications·92 citations·filing 2002–2025
90Inventor score
Files withPIC THERAPEUTICS INC6SANOFI SA6ARTAX BIOPHARMA INC5ALDOUS SUZANNE C2UNIV LELAND STANFORD JUNIOR2
Top patents by PatentIndex Score
24 records- 0195US11753403B2EIF4E inhibitors and uses thereofPIC THERAPEUTICS INC·Filed 2021·Granted Sep 12, 2023·5 cites·21 claims
- 0293US7585834B2Transporters comprising spaced arginine moietiesUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Sep 8, 2009·67 cites·33 claims
- 0386US11807633B2Chromene derivatives as inhibitors of TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2021·Granted Nov 7, 2023·1 cites·20 claims
- 0484US10696663B2Chromene derivatives as inhibitors of TCR-NCK interactionARTAX BIOPHARMA INC·Filed 2019·Granted Jun 30, 2020·2 cites·21 claims
- 0583US12319675B2Chromene derivatives as inhibitors of TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2023·Granted Jun 3, 2025·0 cites·2 claims
- 0682US11008310B2Chromene derivatives as inhibitors of TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2020·Granted May 18, 2021·1 cites·22 claims
- 0781US9937175B2Phenyloxadiazole derivatives as PGDS inhibitorsSANOFI SA·Filed 2016·Granted Apr 10, 2018·2 cites·8 claims
- 0878US2025346586A1Chromene derivatives as inhibitors of tcr-nck interactionARTAX BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 0975US7067698B2Bi-directional synthesis of oligoguanidine transport agentsUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Jun 27, 2006·4 cites·30 claims
- 1075US2025326746A1Eif4e inhibitors and uses thereofPIC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1175US2023190747A1Phenyloxadiazole derivatives as pgds inhibitorsSANOFI SA·Filed 2022·Application pending·0 cites
- 1274US12157731B2EIF4E inhibitors and uses thereofPIC THERAPEUTICS INC·Filed 2023·Granted Dec 3, 2024·0 cites·21 claims
- 1373US8258130B2Pyrimidine hydrazide compounds as PGDS inhibitorsALDOUS SUZANNE C·Filed 2009·Granted Sep 4, 2012·5 cites·24 claims
- 1470US12234231B2EIF4E inhibitors and uses thereofPIC THERAPEUTICS INC·Filed 2022·Granted Feb 25, 2025·0 cites·20 claims
- 1570US9469627B2Phenyloxadiazole derivatives as PGDS inhibitorsVANDEUSEN CHRISTOPHER L·Filed 2012·Granted Oct 18, 2016·3 cites·22 claims
- 1669US8202863B2Pyrimidine amide compounds as PGDS inhibitorsALDOUS SUZANNE C·Filed 2008·Granted Jun 19, 2012·2 cites·28 claims
- 1762US2010081618A1Transporters Comprising Spaced Arginine MoietiesWENDER PAUL A·Filed 2009·Application pending·0 cites
- 1861US2024208961A1Eif4e inhibitors and uses thereofPIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1960US12157732B2eIF4E inhibitors and uses thereofPIC THERAPEUTICS INC·Filed 2022·Granted Dec 3, 2024·0 cites·16 claims
- 2058US2021330671A1Phenyloxadiazole derivatives as pgds inhibitorsSANOFI SA·Filed 2021·Application pending·0 cites
- 2158US2019262338A1Phenyloxadiazole derivatives as pgds inhibitorsSANOFI SA·Filed 2018·Application pending·0 cites
- 2257US2020383982A1Phenyloxadiazole derivatives as pgds inhibitorsSANOFI SA·Filed 2019·Application pending·0 cites
- 2356US2019000845A1Phenyloxadiazole derivatives as pgds inhibitorsSANOFI SA·Filed 2018·Application pending·0 cites
- 2439US2006264608A1Bi-directional synthesis of oligoguanidine transport agentsWENDER PAUL A·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher L. Vandeusen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →